Get Live Data
Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. PureTech Share Price
  4. PureTech Share Regulatory News
  5. Transaction in Own Shares

Pin to quick picksPureTech Regulatory News (PRTC)

PureTech Information

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 234.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.215%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 234.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

15 Aug 2022 07:00

RNS Number : 9341V
PureTech Health PLC
15 August 2022
 

15 August 2022

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:

12 August 2022

Number of ordinary shares purchased:

23,039

Highest price paid per share:

231.00p

Lowest price paid per share:

224.00p

Volume weighted average price paid per share:

226.43p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 4,356,189 ordinary shares in treasury and has 284,333,261 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 284,333,261, which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules. 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others. The Company has created a broad and deep pipeline through the expertise of its experienced research and development team and its extensive network of scientists, clinicians and industry leaders.

This pipeline, which is being advanced both internally and through PureTech's Founded Entities, is comprised of 27 therapeutics and therapeutic candidates, including two that have received both U.S. FDA clearance and European marketing authorization, as of the date of PureTech's most recently filed Annual Report and corresponding Form 6-K. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points based on unique insights in immunology and drug development.

For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

 

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

12/08/2022

13:30:23

219

231

XLON

00312958010TRLO1.1.1

12/08/2022

13:30:23

927

231

XLON

00312958009TRLO1.1.1

12/08/2022

13:29:04

200

229

BATE

00312957773TRLO1.1.1

12/08/2022

13:29:02

300

229

AQXE

00312957764TRLO1.1.1

12/08/2022

13:29:02

240

229

CHIX

00312957763TRLO1.1.1

12/08/2022

13:29:01

382

228.5

XLON

00312957756TRLO1.1.1

12/08/2022

13:05:25

482

228.5

XLON

00312954157TRLO1.1.1

12/08/2022

12:59:53

126

227.5

BATE

00312953421TRLO1.1.1

12/08/2022

12:59:53

54

227.5

CHIX

00312953420TRLO1.1.1

12/08/2022

12:59:53

270

227.5

CHIX

00312953419TRLO1.1.1

12/08/2022

12:59:53

74

227.5

BATE

00312953418TRLO1.1.1

12/08/2022

12:59:44

2300

227.5

XLON

00312953380TRLO1.1.1

12/08/2022

12:29:22

463

225

XLON

00312949010TRLO1.1.1

12/08/2022

12:28:54

43

225

BATE

00312948941TRLO1.1.1

12/08/2022

12:27:12

55

225

CHIX

00312948572TRLO1.1.1

12/08/2022

12:27:12

220

225

CHIX

00312948573TRLO1.1.1

12/08/2022

12:27:09

200

225

XLON

00312948555TRLO1.1.1

12/08/2022

12:27:09

248

225

XLON

00312948554TRLO1.1.1

12/08/2022

12:26:54

22

225

AQXE

00312948511TRLO1.1.1

12/08/2022

12:26:49

129

225

BATE

00312948500TRLO1.1.1

12/08/2022

12:26:49

22

225

BATE

00312948499TRLO1.1.1

12/08/2022

12:25:37

128

225

AQXE

00312948327TRLO1.1.1

12/08/2022

12:25:32

30

225

AQXE

00312948297TRLO1.1.1

12/08/2022

12:25:31

43

225

BATE

00312948295TRLO1.1.1

12/08/2022

12:25:26

55

225

CHIX

00312948271TRLO1.1.1

12/08/2022

12:22:45

130

224.5

TRQX

00312947825TRLO1.1.1

12/08/2022

12:22:45

1868

224.5

XLON

00312947824TRLO1.1.1

12/08/2022

12:22:43

45

224.5

TRQX

00312947817TRLO1.1.1

12/08/2022

12:22:36

4

224.5

TRQX

00312947804TRLO1.1.1

12/08/2022

12:02:08

42

224

BATE

00312944449TRLO1.1.1

12/08/2022

11:53:39

49

224

BATE

00312942917TRLO1.1.1

12/08/2022

11:46:41

62

224.5

CHIX

00312941824TRLO1.1.1

12/08/2022

11:42:44

612

224

XLON

00312941181TRLO1.1.1

12/08/2022

11:35:08

34

224

AQXE

00312939562TRLO1.1.1

12/08/2022

11:35:08

31

224

AQXE

00312939561TRLO1.1.1

12/08/2022

11:35:08

65

224.5

CHIX

00312939560TRLO1.1.1

12/08/2022

11:34:04

50

224.5

BATE

00312939330TRLO1.1.1

12/08/2022

11:28:19

4

224.5

BATE

00312938234TRLO1.1.1

12/08/2022

11:28:19

7

224.5

BATE

00312938235TRLO1.1.1

12/08/2022

11:28:19

43

224.5

BATE

00312938233TRLO1.1.1

12/08/2022

11:28:19

583

225

XLON

00312938232TRLO1.1.1

12/08/2022

11:25:00

57

225

CHIX

00312937684TRLO1.1.1

12/08/2022

11:09:31

455

224.5

XLON

00312935067TRLO1.1.1

12/08/2022

11:06:34

62

225

CHIX

00312934375TRLO1.1.1

12/08/2022

11:04:52

29

224.5

AQXE

00312934009TRLO1.1.1

12/08/2022

11:04:29

127

225

XLON

00312933923TRLO1.1.1

12/08/2022

11:04:29

48

225

BATE

00312933922TRLO1.1.1

12/08/2022

11:04:23

109

225

XLON

00312933905TRLO1.1.1

12/08/2022

11:04:16

147

225

XLON

00312933881TRLO1.1.1

12/08/2022

11:04:16

367

225.5

XLON

00312933880TRLO1.1.1

12/08/2022

11:04:16

60

225.5

CHIX

00312933879TRLO1.1.1

12/08/2022

11:04:16

375

225.5

XLON

00312933878TRLO1.1.1

12/08/2022

10:49:08

55

225

BATE

00312931064TRLO1.1.1

12/08/2022

10:48:14

28

224.5

AQXE

00312930901TRLO1.1.1

12/08/2022

10:48:14

57

224.5

CHIX

00312930900TRLO1.1.1

12/08/2022

10:45:13

9

224.5

CHIX

00312930390TRLO1.1.1

12/08/2022

10:41:32

62

225.5

CHIX

00312929808TRLO1.1.1

12/08/2022

10:41:32

53

225.5

CHIX

00312929809TRLO1.1.1

12/08/2022

10:41:32

58

225.5

CHIX

00312929807TRLO1.1.1

12/08/2022

10:41:32

43

225.5

BATE

00312929806TRLO1.1.1

12/08/2022

10:41:32

51

225.5

BATE

00312929805TRLO1.1.1

12/08/2022

10:41:32

47

225.5

BATE

00312929803TRLO1.1.1

12/08/2022

10:41:32

44

225.5

BATE

00312929804TRLO1.1.1

12/08/2022

10:41:32

52

225.5

BATE

00312929802TRLO1.1.1

12/08/2022

10:41:32

463

225.5

XLON

00312929801TRLO1.1.1

12/08/2022

10:41:32

47

225.5

BATE

00312929800TRLO1.1.1

12/08/2022

10:41:32

46

225.5

BATE

00312929799TRLO1.1.1

12/08/2022

10:41:32

48

225.5

BATE

00312929798TRLO1.1.1

12/08/2022

10:41:32

43

225.5

BATE

00312929797TRLO1.1.1

12/08/2022

10:41:32

312

225.5

BATE

00312929796TRLO1.1.1

12/08/2022

10:41:32

55

225.5

CHIX

00312929795TRLO1.1.1

12/08/2022

10:41:32

53

225.5

CHIX

00312929793TRLO1.1.1

12/08/2022

10:41:32

58

225.5

CHIX

00312929794TRLO1.1.1

12/08/2022

10:41:32

55

225.5

CHIX

00312929791TRLO1.1.1

12/08/2022

10:41:32

55

225.5

CHIX

00312929792TRLO1.1.1

12/08/2022

10:41:32

52

225.5

BATE

00312929790TRLO1.1.1

12/08/2022

10:41:13

32

226.5

AQXE

00312929726TRLO1.1.1

12/08/2022

10:41:13

479

226.5

AQXE

00312929725TRLO1.1.1

12/08/2022

10:41:10

793

227

XLON

00312929721TRLO1.1.1

12/08/2022

10:41:10

500

227

XLON

00312929719TRLO1.1.1

12/08/2022

10:41:10

70

227

XLON

00312929720TRLO1.1.1

12/08/2022

10:41:10

1878

227

XLON

00312929718TRLO1.1.1

12/08/2022

10:41:10

1

226.5

AQXE

00312929717TRLO1.1.1

12/08/2022

09:48:37

551

227

XLON

00312919613TRLO1.1.1

12/08/2022

09:48:37

159

227

XLON

00312919612TRLO1.1.1

12/08/2022

09:48:26

21

226.5

CHIX

00312919595TRLO1.1.1

12/08/2022

09:48:26

32

226.5

CHIX

00312919594TRLO1.1.1

12/08/2022

09:45:00

83

226.5

CHIX

00312918960TRLO1.1.1

12/08/2022

09:41:03

447

226.5

XLON

00312918358TRLO1.1.1

12/08/2022

09:37:31

66

226.5

CHIX

00312917594TRLO1.1.1

12/08/2022

09:36:01

110

226.5

XLON

00312917289TRLO1.1.1

12/08/2022

09:36:01

338

226.5

XLON

00312917288TRLO1.1.1

12/08/2022

09:35:14

31

226.5

CHIX

00312917089TRLO1.1.1

12/08/2022

09:32:24

448

226.5

XLON

00312916630TRLO1.1.1

12/08/2022

09:32:21

58

226.5

CHIX

00312916605TRLO1.1.1

12/08/2022

09:32:21

145

226.5

CHIX

00312916604TRLO1.1.1

12/08/2022

09:32:15

16

226.5

CHIX

00312916587TRLO1.1.1

12/08/2022

09:32:15

13

226.5

CHIX

00312916586TRLO1.1.1

12/08/2022

09:21:15

496

226.5

XLON

00312914307TRLO1.1.1

12/08/2022

09:11:42

476

226.5

XLON

00312912376TRLO1.1.1

12/08/2022

09:02:45

714

226.5

XLON

00312910311TRLO1.1.1

12/08/2022

08:35:51

474

225

XLON

00312904328TRLO1.1.1

12/08/2022

08:35:42

14

225

CHIX

00312904298TRLO1.1.1

12/08/2022

08:35:42

51

225

CHIX

00312904297TRLO1.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFLRTDIVLIF
789101112131415
Date   Source Headline
24th May 20228:05 amRNSPRTC's Vedanta Presents Data at DDW Annual Meeting
24th May 20227:00 amRNSTransaction in Own Shares
23rd May 20227:00 amRNSTransaction in Own Shares
20th May 20227:00 amRNSTransaction in Own Shares
19th May 20227:00 amRNSPDMR Notification RSU Vesting
19th May 20227:00 amRNSTransaction in Own Shares
18th May 20227:00 amRNSTransaction in Own Shares
17th May 202212:00 pmRNSPRTC to Present at UBS Healthcare Conference
17th May 20227:00 amRNSTransaction in Own Shares
16th May 20222:30 pmRNSPRTC Presents LYT-100 Data at ATS Conference
16th May 20227:00 amRNSTransaction in Own Shares
13th May 20227:00 amRNSTransaction in Own Shares
12th May 20227:00 amRNSTransaction in Own Shares
11th May 20227:00 amRNSTransaction in Own Shares
10th May 20227:00 amRNSTransaction in Own Shares
9th May 20227:00 amRNSPRTC Share Buyback Programme Commences Purchases
5th May 20227:00 amRNSPRTC Announces Share Buyback Programme Up to $50M
4th May 202211:35 amRNSGelesis Presents GS200 Weight Loss Data at ECO
3rd May 20227:00 amRNSTotal Voting Rights
29th Apr 202211:05 amRNSGelesis Data: Therapeutic Shows Gut Health Benefit
26th Apr 20227:00 amRNSPRTC Final Results & Publication of Annual Report
13th Apr 20224:44 pmRNSPRTC's Vedanta Publishes VE303 Data
12th Apr 202212:05 pmRNSAkili Depression Data Published in AJP
12th Apr 20227:00 amRNSGlyph: 20x Oral Bioavailability of Buprenorphine
7th Apr 20227:00 amRNSNotice of Results
1st Apr 20227:00 amRNSTotal Voting Rights
24th Mar 20227:00 amRNSPRTC Appoints Merck Vet to BOD & Audit Committee
17th Mar 20221:05 pmRNSAkili Adds Gaming Vet as Chief Product Officer
16th Mar 202210:35 amRNSGelesis: Record-Breaking Plenity Prescriptions
8th Mar 202212:05 pmRNSAkili Named to World's Most Innovative Companies
18th Feb 20224:30 pmRNSHolding(s) in Company
17th Feb 202212:05 pmRNSAkili Data: Enhanced Brain Activity in Kids w/ADHD
15th Feb 20227:00 amRNSPRTC's Akili Files Registration Statement on S-4
10th Feb 202212:00 pmRNSPRTC to Present at Leerink Healthcare Conference
4th Feb 20227:00 amRNSPDMR DEALING - PURCHASE OF SHARES
31st Jan 202211:50 amRNSPRTC's Gelesis Launches Plenity Media Campaign
26th Jan 202212:02 pmRNSPRTC’s Akili to Become Public & $162M Funding
14th Jan 20227:00 amRNSPRTC's Gelesis to Debut on NYSE Today Ticker GLS
7th Jan 202212:00 pmRNSPureTech to Present at JPM Healthcare Conference
6th Jan 20227:00 amRNSLYT-100 Shows Improved AE Profile vs Pirfenidone
5th Jan 202212:05 pmRNSGelesis Adds to BOD & Declared Effective by SEC
20th Dec 20217:00 amRNSPDMR DEALING - PURCHASE OF SHARES
16th Dec 20217:00 amRNSPRTC Provides Recap Ahead of Catalyst-Rich 2022
8th Dec 202112:00 pmRNSPRTC Presents Data at ACNP Conference For LYT-300
7th Dec 202112:00 pmRNSPRTC's Lymphatic Platform Candidate Human Study
1st Dec 202112:10 pmRNSPRTC: Gelesis' Plenity Now Broadly Available in US
1st Dec 20217:00 amRNSTotal Voting Rights
18th Nov 202112:10 pmRNSPRTC's Gelesis Receives $30M Plenity Order from Ro
16th Nov 202112:00 pmRNSPRTC Publishes Previous LYT-100 MAD Study Results
15th Nov 202112:00 pmRNSPRTC Presents at Two Upcoming Investor Conferences
789101112131415

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.